Status:
NOT_YET_RECRUITING
Cardiac Index, SVR/SVRI During Weaning From ECC- Data Obtained From Femoral and Radial Artery Transducer
Lead Sponsor:
George Papanicolaou Hospital
Conditions:
Coronary Artery Disease
Aortic Valve Disease
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Swan Ganz catheter-Edwards Lifesciences obtains values of cardiac output/index and systemic vascular resistance/index using the mean artery pressure of either radial or femoral artery. During weaning...
Detailed Description
50 consecutive cardiac surgical patients undergoing on-pump primary coronary artery bypass, valve replacement or combined surgery are included in the study. Cardiac output is measured sequentially by ...
Eligibility Criteria
Inclusion
- Coronary artery disease , aortic valve stenosis, aortic valve regurgitation, mitral valve stenosis, mitral valve regurgitation,
Exclusion
- none
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06112561
Start Date
January 1 2024
End Date
May 1 2024
Last Update
January 17 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.